Detalhe da pesquisa
1.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med
; 385(16): 1451-1461, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449189
2.
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.
Circulation
; 146(9): 676-686, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762322
3.
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
Circulation
; 144(16): 1284-1294, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459213
4.
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Circulation
; 143(4): 326-336, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081531
5.
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial.
Circulation
; 143(4): 337-349, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33175585
6.
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
Circulation
; 139(3): 351-361, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586723
7.
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial.
Diabetes Obes Metab
; 22(7): 1062-1073, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037653
8.
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
JAMA
; 321(1): 69-79, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30418475
9.
Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children.
J Am Soc Nephrol
; 28(10): 3055-3065, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566477
10.
ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.
J Am Soc Nephrol
; 27(1): 63-8, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25967120
11.
Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans.
J Antimicrob Chemother
; 71(8): 2241-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141088
12.
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials.
JAMA Cardiol
; 9(2): 134-143, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170502
13.
Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases.
Int J Cancer
; 133(2): 362-72, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23338788
14.
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial.
JACC Heart Fail
; 11(4): 407-417, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881400
15.
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.
Clin Kidney J
; 14(9): 2136, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476096
16.
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial.
Clin Kidney J
; 14(1): 226-236, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564423
17.
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.
Diabetes Care
; 43(8): 1803-1812, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32444457
18.
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial.
Diabetol Int
; 11(2): 129-141, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32206483
19.
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial.
Eur J Heart Fail
; 22(12): 2383-2392, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33251670
20.
In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival.
Bone
; 127: 188-198, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31233932